Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The HIV response is a shared global commitment to equitable health outcomes.
On World AIDS Day, Timothy Ray Brown, the first person cured of HIV, will get a star on the Palm Springs Walk of Stars.
While not cured, the man has maintained viral suppression for more than two decades after stopping antiretroviral therapy.
The first three people who received the experimental therapy experienced no serious adverse effects or toxicities.
Two of 11 people who received four doses of budigalimab maintained viral suppression for a year and a half after stopping antiretrovirals.
Latently infected cells continue to produce viral RNA and proteins, and even defective HIV can trigger persistent immune activation.
The man, who was diagnosed with HIV in 1990, received chemotherapy and radiation followed by a stem cell transplant in July 2018.
The drug reduces the life span of cells harboring latent virus and blocks inflammation that allows the reservoir to persist.
Experimental gene therapy excises HIV-like virus from infected cells in monkeys.
Potential cure strategy builds on unexpected findings about hematopoietic stem cells.
Ruxolitinib might have contributed to a functional cure after a stem cell transplant without a rare mutation.
Researchers preview studies on circumcision, PrEP for women, mpox, COVID-19 and HIV functional cure.
A new case raises questions about the keys to success for a functional cure after a stem cell transplant.
IAS 2023 will feature the latest news on HIV prevention, treatment and cure research.
44% of children treated with two bnAbs maintained viral suppression after stopping antiretrovirals.
The 12th IAS Conference on HIV Science will feature an array of late-breaking advances in HIV prevention, treatment and cure research.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.